Literature DB >> 22289176

Cyclin-dependent kinase 4 is a novel target in micoRNA-195-mediated cell cycle arrest in bladder cancer cells.

Yiwei Lin1, Jian Wu, Hong Chen, Yeqing Mao, Yunfu Liu, Qiqi Mao, Kai Yang, Xiangyi Zheng, Liping Xie.   

Abstract

miRNAs are a class of small-noncoding RNAs capable of negatively regulating gene expression. Here, we found that miR-195 is down-regulated in human bladder cancer tissue versus normal adjacent tissue. To better characterize the role of miR-195 in bladder cancer, we conducted gain of function analysis by transfecting bladder cancer cell line T24 with chemically synthesized miR-195 mimic. We identified CDK4, an early G1 cell cycle regulator, as a novel target of miR-195. Selective over-expression of miR-195 could induce G1-phase arrest in T24 cells, and subsequently inhibit T24 cell growth. These findings indicate that miR-195 could be a potential tumor suppressor in bladder cancer. Copyright Â
© 2012 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22289176     DOI: 10.1016/j.febslet.2012.01.027

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  45 in total

1.  Cooperative Repression of Insulin-Like Growth Factor Type 2 Receptor Translation by MicroRNA 195 and RNA-Binding Protein CUGBP1.

Authors:  Yuan Zhang; Yun Zhang; Lan Xiao; Ting-Xi Yu; Jun-Zhe Li; Jaladanki N Rao; Douglas J Turner; Myriam Gorospe; Jian-Ying Wang
Journal:  Mol Cell Biol       Date:  2017-09-12       Impact factor: 4.272

2.  MicroRNA-576-3p inhibits proliferation in bladder cancer cells by targeting cyclin D1.

Authors:  Zhen Liang; Shiqi Li; Xin Xu; Xianglai Xu; Xiao Wang; Jian Wu; Yi Zhu; Zhenghui Hu; Yiwei Lin; Yeqing Mao; Hong Chen; Jindan Luo; Ben Liu; Xiangyi Zheng; Liping Xie
Journal:  Mol Cells       Date:  2014-12-30       Impact factor: 5.034

3.  Changes in liver microRNA expression and their possible regulatory role in energy metabolism-related genes in hibernating black bears.

Authors:  Kazuhei Nishida; Michito Shimozuru; Yuko Okamatsu-Ogura; Mitsunori Miyazaki; Tsukasa Soma; Mariko Sashika; Toshio Tsubota
Journal:  J Comp Physiol B       Date:  2021-01-18       Impact factor: 2.200

4.  Regulation of growth of human bladder cancer by miR-192.

Authors:  Yongchao Jin; Jiasun Lu; Jiling Wen; Yinzhou Shen; Xiaofei Wen
Journal:  Tumour Biol       Date:  2015-01-09

5.  MicroRNA-195 inhibits proliferation of cervical cancer cells by targeting cyclin D1a.

Authors:  Ning Wang; Heng Wei; Duo Yin; Yanming Lu; Yao Zhang; Qiao Zhang; Xiaoxin Ma; Shulan Zhang
Journal:  Tumour Biol       Date:  2015-10-28

6.  MiR-133a suppresses the migration and invasion of esophageal cancer cells by targeting the EMT regulator SOX4.

Authors:  Shujun Li; Xuebo Qin; Yang Li; Xun Zhang; Ren Niu; Helin Zhang; Airong Cui; Wenting An; Xiaolu Wang
Journal:  Am J Transl Res       Date:  2015-08-15       Impact factor: 4.060

Review 7.  Posttranscriptional regulation of intestinal epithelial integrity by noncoding RNAs.

Authors:  Jun-Yao Wang; Lan Xiao; Jian-Ying Wang
Journal:  Wiley Interdiscip Rev RNA       Date:  2016-10-04       Impact factor: 9.957

8.  Eribulin upregulates miR-195 expression and downregulates Wnt3a expression in non-basal-like type of triple-negative breast cancer cell MDA-MB-231.

Authors:  Kanji Furuya; Akiko Sasaki; Yuko Tsunoda; Mayumi Tsuji; Yuko Udaka; Hideto Oyamada; Hiromichi Tsuchiya; Katsuji Oguchi
Journal:  Hum Cell       Date:  2015-11-16       Impact factor: 4.174

Review 9.  Aberrant expression of microRNAs in bladder cancer.

Authors:  Hirofumi Yoshino; Naohiko Seki; Toshihiko Itesako; Takeshi Chiyomaru; Masayuki Nakagawa; Hideki Enokida
Journal:  Nat Rev Urol       Date:  2013-05-28       Impact factor: 14.432

Review 10.  MicroRNA-338-3p suppresses metastasis of lung cancer cells by targeting the EMT regulator Sox4.

Authors:  Yang Li; Peirui Chen; Lingling Zu; Bin Liu; Min Wang; Qinghua Zhou
Journal:  Am J Cancer Res       Date:  2016-01-15       Impact factor: 6.166

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.